ИММУННЫЙ ОТВЕТ К КАПСУЛЬНЫМ ПОЛИСАХАРИДАМ STREPTOCOCCUS PNEUMONIAE У ДЕТЕЙ С ИЗБЫТОЧНОЙ МАССОЙ ТЕЛА, ПРИВИТЫХ 13-ВАЛЕНТНОЙ КОНЪЮГИРОВАННОЙ ВАКЦИНОЙ ПРОТИВ ПНЕВМОКОККОВОЙ ИНФЕКЦИИ

Abstract

Objective of the research: to determine IgG antibodies (AB) to S. pneumoniae serotypes in overweight children after administration of a 13-valent pneumococcal conjugate vaccine (PCV13). Materials and methods: blood serum of 17 children with excess BW (main group) and 40 children with normal BW (control group) aged 3 to 7 years, vaccinated with PCV13 were examined. The method of solid phase ELISA was used for determination of IgG AB levels to a mixture of capsular polysaccharides (CPS) of pneumococcus contained in PCV13 and serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, 23F S. pneumoniae, after 6 months after vaccination with PCV13. Results: all children had post-vaccination specific AB to pneumococcal serotypes in the value higher than the negative control. In the main group, the mean values of IgG AB to 5 of 13 S. pneumoniae serotypes 7F, 9V, 18C, 19A, 23F and to the mixture of CPS in the vaccine were higher than in the control group, as well as the proportion of children with high (more than 100 cu) levels of IgG AB to the mixture of PCV13 CPS and to the pneumococcal serotype 18C in comparison with the control. Further study of the immune response to pneumococcal vaccination in children with metabolic disorders is needed.